1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. POINT-OF-CARE GENETIC TESTING MARKET BY TYPE
5.1. Introduction
5.2. Polymerase Chain Reaction (PCR)
5.3. Isothermal Amplification
5.4. Others
6. POINT-OF-CARE GENETIC TESTING MARKET BY APPLICATION
6.1. Introduction
6.2. Infectious Disease
6.3. Cancer Screening
6.4. Personalized Medicine
6.5. Others
7. POINT-OF-CARE GENETIC TESTING MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Specialized Clinics
7.4. Others
8. POINT-OF-CARE GENETIC TESTING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Abbott
10.2. F. Hoffmann-La Roche Ltd
10.3. Thermo Fisher Scientific Inc.
10.4. Qiagen N.V.
10.5. Bio-Rad Laboratories, Inc.
10.6. Becton Dickinson
10.7. Danaher Corporation
10.8. bioMérieux
10.9. Siemens Healthineers AG
10.10. OraSure Technologies Inc
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES